Mucor in a Viral Land: A Tale of Two Pathogens

PURPOSE: COVID-19 infection, its treatment, resultant immunosuppression, and pre-existing comorbidities have made patients vulnerable to secondary infections including mucormycosis. It is important to understand the presentation, temporal sequence, risk factors, and outcomes to undertake measures fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Mrittika, Lahane, Sumeet, Lahane, Tatyarao P, Parekh, Ragini, Honavar, Santosh G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933891/
https://www.ncbi.nlm.nih.gov/pubmed/33463566
http://dx.doi.org/10.4103/ijo.IJO_3774_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933891/
https://www.ncbi.nlm.nih.gov/pubmed/33463566
http://dx.doi.org/10.4103/ijo.IJO_3774_20

Ejemplares similares